SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
10 03 2023
Historique:
received: 02 09 2022
revised: 09 11 2022
accepted: 14 11 2022
pubmed: 27 11 2022
medline: 7 3 2023
entrez: 26 11 2022
Statut: ppublish

Résumé

The preclinical time course of SARS-CoV-2 shedding is not well-described. Understanding this time course will help to inform risk of SARS-CoV-2 transmission. During an outbreak in a congregate setting, we collected paired mid-turbinate nasal swabs for antigen testing and reverse-transcription polymerase chain reaction (RT-PCR) every other day from all consenting infected and exposed persons. Among 12 persons tested prospectively before and during SARS-CoV-2 infection, ten of 12 participants (83%) had completed a primary COVID-19 vaccination series prior to the outbreak. We recovered SARS-CoV-2 in viral culture from 9/12 (75%) of participants. All three persons from whom we did not recover SARS-CoV-2 in viral culture had completed their primary vaccination series. We recovered SARS-CoV-2 from viral culture in 6/9 vaccinated persons and before symptom onset in 3/6 symptomatic persons. These findings underscore the need for both non-pharmaceutical interventions and vaccination to mitigate transmission.

Identifiants

pubmed: 36435706
pii: S0264-410X(22)01428-1
doi: 10.1016/j.vaccine.2022.11.030
pmc: PMC9671797
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1769-1773

Informations de copyright

Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1139-1143
pubmed: 32817597
Microbiol Spectr. 2022 Feb 23;10(1):e0153221
pubmed: 34985301
Emerg Infect Dis. 2020 Jun;26(6):1266-1273
pubmed: 32160149
J Infect Chemother. 2022 Feb;28(2):347-351
pubmed: 34774431
Emerg Infect Dis. 2021 Feb;27(2):352-359
pubmed: 33275874
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447
J Infect Dis. 2021 Sep 1;224(5):771-776
pubmed: 33693830
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMC Infect Dis. 2021 Dec 27;21(1):1282
pubmed: 34961470
Nat Med. 2022 Jul;28(7):1491-1500
pubmed: 35395151

Auteurs

David W McCormick (DW)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States; United States Public Health Service, Rockville, MD, United States. Electronic address: yup1@cdc.gov.

Liesl M Hagan (LM)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Phillip P Salvatore (PP)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; United States Public Health Service, Rockville, MD, United States. Electronic address: pgx5@cdc.gov.

Reed Magleby (R)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Christine Lee (C)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Sadia Sleweon (S)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Lavinia Nicolae (L)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Tom Dixon (T)

Bureau of Prisons, U.S. Department of Justice, Washington, DC, United States.

Robert Banta (R)

Bureau of Prisons, U.S. Department of Justice, Washington, DC, United States.

Isaac Ogle (I)

United States Public Health Service, Rockville, MD, United States; Bureau of Prisons, U.S. Department of Justice, Washington, DC, United States.

Cristen Young (C)

Bureau of Prisons, U.S. Department of Justice, Washington, DC, United States.

Charles Dusseau (C)

Bureau of Prisons, U.S. Department of Justice, Washington, DC, United States.

Charles Ogden (C)

United States Public Health Service, Rockville, MD, United States; Bureau of Prisons, U.S. Department of Justice, Washington, DC, United States.

Hannah Browne (H)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

John Michael Metz (J)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Min-Hsin Chen (MH)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Maria I Solano (MI)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Shannon Rogers (S)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Alex Burgin (A)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Mili Sheth (M)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Bettina Bankamp (B)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Azaibi Tamin (A)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Jennifer L Harcourt (JL)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Jacqueline E Tate (JE)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; United States Public Health Service, Rockville, MD, United States.

Hannah L Kirking (HL)

COVID-19 Pandemic Response Team, Centers for Disease Control and Prevention, Atlanta, GA, United States; United States Public Health Service, Rockville, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH